# Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

> **NCT00557102** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute, France** · enrollment: 24 (actual)

## Conditions studied

- Colorectal Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **BIOLOGICAL:** filgrastim
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium

## Key facts

- **NCT ID:** NCT00557102
- **Lead sponsor:** National Cancer Institute, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557102, "Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00557102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*